Low Pass Whole Genome Sequencing in WISDOM 2.0
Expanded Genetic Test in WISDOM 2.0 On June 1st, 2023 WISDOM implemented a new method for analyzing one component of participants’ genetic risk (their polygenic risk score) which gets factored into personalized risk assessment for breast cancer. The new technology upgrade, known as Low Pass Whole Genome Sequencing (lpWGS) enables our researchers to analyze a […]